Edesa Biotech (EDSA) Shares Outstanding (2013 - 2026)

Edesa Biotech has reported Shares Outstanding (Entity) for 13 years, with the latest figure at $8.3 million in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 140.33% year-over-year to $8.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.3 million (up 140.33% YoY) and the FY2025 annual result came in at $5.7 million, up 74.81% from the prior year.
• Shares Outstanding (Entity) rose to $8.3 million in Q4 2025 per EDSA's latest filing, from $5.7 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $8.3 million in Q4 2025 and troughed at $1.9 million in Q1 2021.
• A 5-year average of $3.4 million and a median of $3.0 million in 2023 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) grew 5.59% in 2024, then surged 140.33% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $1.9 million in 2021, then soared by 43.16% to $2.8 million in 2022, then climbed by 14.46% to $3.2 million in 2023, then advanced by 9.57% to $3.5 million in 2024, then soared by 140.33% to $8.3 million in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $8.3 million, $5.7 million, and $7.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.